July 2015 FDA Recall Drug by Novartis Pharmaceuticals Corp.
D-1430-2015 - Failed Dissolution Specifications

This Class III drug recall was voluntarily initiated by Novartis Pharmaceuticals Corp. on July 28, 2015 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed in NJ - site for distributor and the recall is currently terminated.

Recall Number: D-1430-2015

Reason for Recall
Failed Dissolution Specifications: Product is being recalled due to out of specification (above specification) result obtained at 6-hour dissolution time point during the 12-month stability testing.
Initiated
07-28-2015
Reported
09-23-2015
Quantity
10,767 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Novartis Pharmaceuticals Corp.
NJ - site for distributor
Dexmethylphenidate HCl Extended-Release, Capsules, 10mg, Rx only, 100 Capsules. Manufactured by Alkermes Gainesville LLC Gainesville, GA 30504 for Sandoz Inc. Princeton, NJ 08540

Batch or Lot Expiration Information

Lot# : F0002, Exp 12/2016